Kolkata: Modern Diagnostic & Research Centre is a diagnostic chain in India and it offering a wide range of pathology and radiology services. The company
provides diagnostic tests, home specimen collection, online reports and customised test packages for institutional customers and patients. It has 21 centers of which 18 are laboratories and three are diagnostic centers which are spread across eight states.
The SMI IPO bidding window is opening today, the last day of a record-setting year when about 375 mainboard and SME public issues hit Dalal Street and the mainboard issues raised as much as Rs 1.75 lakh from the market. Modern Diagnostic IPO is a book build pubic issue which intends to mobilise Rs 36.89 crore from the market through issue of 0.41 crore fresh shares. It has no OFS part.
Modern Diagnostic IPO GMP rises
According to investorgain, Modern Diagnostic SME IPO GMP stood at Rs 10 in early morning of Dec 31. It jumped to this level from zero on Dec 30. With the price band of Rs 90, the estimated listing price will be Rs 100 and the listing gain 11.11%. However, it must be remembered that GMP is an unofficial gauge, is volatile and cannot guarantee any listing gain (or loss).
Modern Diagnostic IPO price band, lot size
The Modern Diagnostic IPO price band has been set at Rs 85-90. The minimum investible lot for a retail investor is 1,600 shares for a retail investor which will entail an application amount of Rs 2,88,000 based on the upper price. For HNIs the minimum lot size for investment is three lots or 4,800 shares.
Beeline Capital Advisors is the book running lead manager, while MUFG Intime India has been appointed the registrar of the issue and the Market Maker of the company is Spread X Securities. The listing will be done on BSE SME on Jan 7, 2026.
Modern Diagnostic IPO key dates
Bid opens: Today, Dec 31, 2025
Bid closes: Jan 2, 2026
Allotment: Jan 5
Refund: Jan 6
Credit of shares to demat: Jan 6
Listing: Jan 7
(Disclaimer: This article is only meant to provide information. News9 does not recommend buying or selling shares or subscriptions of any IPO, Mutual Funds, precious metals, commodity, REITs, InvITs and any form of alternative investment instruments and crypto assets.)
